Mega CapHealthcareDividend

MRK — Merck & Co., Inc.

Pharmaceuticals · Founded 1891 · Rahway, New Jersey · CEO: Robert Davis

Merck is a global pharmaceutical and animal health company known for Keytruda, the world's best-selling cancer immunotherapy drug. The company has a strong pipeline in oncology, vaccines, and cardiometabolic diseases and operates one of the largest animal health businesses globally.

How Merck & Co., Inc. Makes Money

Pharmaceutical segment led by Keytruda (cancer immunotherapy) and Gardasil (HPV vaccine)

Animal Health segment (Bravecto, livestock vaccines, companion animal products)

Other oncology drugs and hospital acute care products

Licensing and collaboration revenue from pipeline partnerships

Key Metrics Investors Watch

Keytruda revenue growth and market share across cancer indications
Pipeline clinical data readouts (especially Keytruda successors)
Gardasil/HPV vaccine global uptake
Animal Health segment growth
2028 Keytruda patent cliff preparation

Competitive Advantages

Keytruda is the world's best-selling drug and dominant cancer immunotherapy across 30+ tumor types
Strong oncology pipeline including subcutaneous Keytruda, ADCs, and next-generation immuno-oncology
Gardasil HPV vaccine has growing global demand, especially in emerging markets
Animal Health provides stable, non-pharma diversification

Key Risks

Extreme concentration risk — Keytruda represents over 40% of total revenue
Keytruda patent cliff (approximately 2028) requires successful pipeline execution
Gardasil demand fluctuations in key markets (especially China)
Drug pricing reform and government negotiation authority under the Inflation Reduction Act

Dividend & Capital Return

Merck pays a reliable quarterly dividend that has been increased consistently. The dividend is well-covered by Keytruda-driven free cash flow.

I Document Every Trade — Even the Losses

Options record: 1W-8L. Net worth: 100% GSE preferred. Get the unfiltered updates.

Unsubscribe anytime. I respect your inbox more than Congress respects property rights.

Frequently Asked Questions

Is Merck stock a good investment?

Merck offers strong current earnings from Keytruda but faces a critical patent cliff around 2028. The investment case hinges on the pipeline's ability to replace Keytruda revenue. This is educational content, not financial advice.

What is Keytruda?

Keytruda (pembrolizumab) is a cancer immunotherapy drug that helps the immune system fight cancer. It is approved across 30+ tumor types and is the world's best-selling pharmaceutical product.

Does Merck pay a dividend?

Yes, Merck pays a quarterly dividend that has been consistently increased. The dividend is well-supported by the company's strong cash flow.

When does Keytruda lose patent protection?

Keytruda's key patents expire around 2028. Merck is actively developing next-generation oncology assets and a subcutaneous formulation of Keytruda to extend its lifecycle.

What are the risks to Merck stock?

The primary risk is Keytruda concentration — if Merck cannot replace Keytruda revenue through its pipeline as patents expire, earnings could decline significantly.

Related Stocks

JNJ

Johnson & Johnson

Healthcare

Johnson & Johnson is a global healthcare company operating in pharmaceuticals (Innovative Medicine) and medical devices (MedTech). Following the spin-off of its consumer health division as Kenvue in 2023, JNJ is now focused on higher-growth, higher-margin healthcare segments.

ABBV

AbbVie Inc.

Healthcare

AbbVie is a global biopharmaceutical company focused on immunology, oncology, neuroscience, and eye care. Spun off from Abbott Laboratories in 2013, AbbVie is best known for Humira (the world's best-selling drug of all time) and its successor drugs Skyrizi and Rinvoq.

LLY

Eli Lilly and Company

Healthcare

Eli Lilly is a global pharmaceutical company at the center of the GLP-1 / obesity drug revolution. Mounjaro (tirzepatide) for diabetes and Zepbound for weight loss have made Lilly one of the fastest-growing and most valuable pharmaceutical companies in the world.

PFE

Pfizer Inc.

Healthcare

Pfizer is one of the world's largest pharmaceutical companies, with a diversified portfolio spanning oncology, immunology, rare diseases, vaccines, and hospital medicines. The company became globally prominent during the COVID-19 pandemic through its co-developed mRNA vaccine (Comirnaty) with BioNTech and antiviral pill Paxlovid. Post-pandemic, Pfizer has focused on restoring growth through acquisitions including Seagen (oncology) and deploying its substantial cash reserves. The company faces significant patent cliffs on several major drugs in the late 2020s.

Recommended Resources

Tools & books I actually use and recommend

SeekingAlpha Premium

Quant ratings, earnings transcripts, and the stock analysis community where I published 300+ articles.

Try SeekingAlpha

The Intelligent Investor

Ben Graham's timeless guide to value investing. The book Warren Buffett calls "the best investing book ever written."

View on Amazon

Interactive Brokers

Low commissions, global market access, and professional-grade tools. This is where I hold my positions.

Open an Account

Some links above are affiliate links. I only recommend products I personally use. See my full disclosures.

Keep Exploring

Hub

All Stocks

Browse all 134 stock profiles by sector.

Best Stocks For Beginners

Curated stock picks for new investors by goal.

Financial Glossary

Understand the terms investors use every day.

Stock vs ETF

Individual stocks vs ETFs — which is right for you?

ETF Profiles

Deep dives on 90+ ETFs across every category.

Buying Your First Stock

How to open a brokerage and buy your first share.

Browse All 134 Stock Profiles

Company information is based on publicly available disclosures and widely-known business facts. No specific price, earnings, or real-time market data is included. This is educational content — not investment advice.